Liza Villaruz, Md

This study is testing whether giving standard immunotherapy in the morning versus the afternoon makes it work better for patients with advanced cancer. It will enroll 350 people with advanced lung cancer or other solid tumors who are starting immunotherapy for the first time. Par…